TMCI

#3097
Treace Medical Concepts, Inc. - Common Stock
3.4 6 USD
+12.34%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
3.46
3.46
Faixa anual
1.17
7.78
Mudança diária
+12.34%
Mudança mensal
+95.48%
Mudança em 6 meses
+18.49%
Mudança anual
-40.45%
Fechamento anterior
3.0 8
Open
3.4 6
Mínimo
3.4 6
High
3.4 6
Volume
60
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 224.46 M
  • Employee 450
  • Founded 2014
  • CEO N/A
  • Website www.treace.com
  • Headquarter Florida, United States
  • FIGI BBG00GQKR6M4
  • Industry Dispositivos médicos
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-2.63
Índice preço/fluxo de caixa
0.73

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

Notícias